<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35587278</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1433-8491</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>European archives of psychiatry and clinical neuroscience</Title>
          <ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analysis of malingered psychological symptoms in a clinical sample for early detection in initial interviews.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-022-01422-8</ELocationID>
        <Abstract>
          <AbstractText>Malingering consists of the production of false physical or psychological symptoms motivated by external incentives that are normally reproduced in pathologies that are not related to organic origin or there are no laboratory tests for their diagnosis, as is the case of mixed anxiety-depressive disorder and fibromyalgia syndrome. The objective of this research consisted of comparing the profile of simulative patients with fibromyalgia and mixed anxiety-depressive disorder to obtain a profile and facilitate its detection in initial interviews. The research was carried out with 78 patients (42 patients with fibromyalgia and 36 patients with mixed anxiety-depressive disorder) who were administered the professional's structured clinical judgment, the Beck Depression Inventory, the State-Trait Anxiety Questionnaire, and the Structured Symptom Simulation Inventory. The main obtained results show that the simulation classification proposed by the questionnaire is in the range of 66.67-80% with regard to coinciding with the judgment of experts, and people with suspicion of simulation of both groups of patients present similar characteristics. The simulators thus present incongruous responses in relation to the questionnaires, and high levels of trait anxiety, state, and depression predict the simulation of symptoms.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barbosa-Torres</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-2767-1536</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Anthropology, University of Extremadura, 06006, Badajoz, Spain. carlosbarbosa@unex.es.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bueso-Izquierdo</LastName>
            <ForeName>Natalia</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-2469-8867</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychology and Anthropology, University of Extremadura, 06006, Badajoz, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cubo-Delgado</LastName>
            <ForeName>Sixto</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-8802-9980</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Educational Sciences, University of Extremadura, 06006, Badajoz, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA>
        <NlmUniqueID>9103030</NlmUniqueID>
        <ISSNLinking>0940-1334</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anxiety</Keyword>
        <Keyword MajorTopicYN="N">Depression</Keyword>
        <Keyword MajorTopicYN="N">Fibromyalgia</Keyword>
        <Keyword MajorTopicYN="N">Malingering</Keyword>
        <Keyword MajorTopicYN="N">Mixed anxiety–depressive disorder</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>11</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35587278</ArticleId>
        <ArticleId IdType="doi">10.1007/s00406-022-01422-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s00406-022-01422-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adamczyk WM, Luedtke K, Buglewicz E, Bąbel P (2018) Pain rewarded: hyperalgesic and allodynic effect of operant conditioning in healthy humans—protocol for a systematic review and meta-analysis. Syst Rev 7(1):93. https://doi.org/10.1186/s13643-018-0765-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13643-018-0765-y</ArticleId>
            <ArticleId IdType="pubmed">30016996</ArticleId>
            <ArticleId IdType="pmc">6050731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th Edition). DSM-5. Washington, DC</Citation>
        </Reference>
        <Reference>
          <Citation>Angel-Garcia D, Martinez-Nicolas I, Saturno-Hernández PJ (2016) Clinical approach to fibromyalgia: Synthesis of evidence-based recommendations, a systematic review. Reumatol Clín 12:65–71. https://doi.org/10.1016/j.reuma.2015.06.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.reuma.2015.06.001</ArticleId>
            <ArticleId IdType="pubmed">26481494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aparicio VA, Ortega FB, Carbonell-Baeza A, Cuevas AM, Delgado-Fernández M, Ruiz J (2013) Ansiedad, depresión y su relación con el dolor y la gravedad de la fibromialgia. Behav Psychol 21(2):381–392</Citation>
        </Reference>
        <Reference>
          <Citation>Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Macfarlane GJ et al (2019) AAPT diagnostic criteria for fibromyalgia. J Pain 20(6):611–628. https://doi.org/10.1016/j.jpain.2018.10.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2018.10.008</ArticleId>
            <ArticleId IdType="pubmed">30453109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold LM, Hudson LI, Keck PE, Auchencback MB, Javaras KN, Hess EV (2006) Comorbidity of fibromyalgia and psychiatric disorder. J Clin Psychiatriy 67(8):1219–1225. https://doi.org/10.4088/jcp.v67n0807</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4088/jcp.v67n0807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bair MJ, Krebs EE (2020) Fibromyalgia. Ann Intern Med 172(5):ITC33</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/AITC202003030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bass C, Wade DT (2019) Malingering and factitious disorder. Pract Neurol 19:96–105. https://doi.org/10.1136/practneurol-2018-001950</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/practneurol-2018-001950</ArticleId>
            <ArticleId IdType="pubmed">30425128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becerra-García JA (2016) Valoración psicométrica de la simulación de síntomas psíquicos en el ámbito forense. Revista Española de Medicina Legal 42(1):41–44. https://doi.org/10.1016/j.reml.2015.10.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.reml.2015.10.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blasco-Saiz JL, Pallardó-Durá L (2013) Detección de exageración de síntomas mediante el SIMS y el MMPI-2-RF en pacientes diagnosticados de trastorno mixto ansioso-depresivo y adaptativo en el contexto medicolegal: un estudio preliminar. Clínica y Salud 24(3):177–183. https://doi.org/10.5093/cl2013a19</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5093/cl2013a19</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL (2017) Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos. Med Clin 149(10):441–448</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.medcli.2017.06.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capilla-Ramírez P, y González-Ordi H, Santamaría P (2009) Tasas de prevalencia de simulación: un estudio empírico basado en profesionales médicos expertos. In: Comunicación presentada en el IX Congreso Nacional de la Sociedad Española de Traumatología Laboral—SETLA. Barcelona, 26–28 de Noviembre</Citation>
        </Reference>
        <Reference>
          <Citation>Capilla-Ramírez P, González-Ordi H, Santamaría P, Pérez-Nieto MA, Casado-Morales MI (2013) Fibromialgia: ¿exageración o simulación? Clínica y Salud 24(3):185–195. https://doi.org/10.1016/S1130-5274(13)70020-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1130-5274(13)70020-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmona L, Ballina J, Gabriel R, Laffon A (2001) The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60(11):1040–1045. https://doi.org/10.1136/ard.60.11.1040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.60.11.1040</ArticleId>
            <ArticleId IdType="pubmed">11602475</ArticleId>
            <ArticleId IdType="pmc">1753418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clegg C, Fremouw W, Mogge N (2009) Utility of the Structured Inventory of Malingered Symptomatology (SIMS) and the Assessment of Depression Inventory (ADI) in screening for malingering among outpatients seeking to claim disability. J Forensic Psychiatry Psychol 20:239–254</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14789940802267760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemente-Suárez VJ (2020) Multidisciplinary intervention in the treatment of mixed anxiety and depression disorder. Physiol Behav 219:112858. https://doi.org/10.1016/j.physbeh.2020.112858</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.physbeh.2020.112858</ArticleId>
            <ArticleId IdType="pubmed">32109486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conde V, Useros E (1975) Adaptación castellana de la escala de evaluación conductual para la depresión de Beck. Revista de Psiquiatría y Psicología Médica 12:217–236</Citation>
        </Reference>
        <Reference>
          <Citation>Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP et al (2018) Dimensionality and Reliability of the Central Sensitization Inventory (CSI) in a pooled multicountry sample. J Pain 19(3):317–329. https://doi.org/10.1016/j.jpain.2017.11.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2017.11.006</ArticleId>
            <ArticleId IdType="pubmed">29198933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curtis KL, Aguerrevere LE, Bianchini KJ, Greve KW, Nicks RC (2019) Detecting malingered pain-related disability with the pain catastrophizing scale: a criterion groups validation study. Clin Neuropsychol 33(8):1485–1500</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13854046.2019.1575470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Díaz-Robledo LA, Robles-Sánchez JI (2014) ¿Es la Fibromialgia un trastorno depresivo con síntomas somáticos o es un síndrome de sensibilización central con comorbilidad depresiva? Sanidad Militar 7(2):7–87. https://doi.org/10.4321/S1887-85712014000200003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4321/S1887-85712014000200003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dueñas Laita A, Ruiz Mambrilla MM, Pérez Castrillón JL (2018) Síndromes de sensibilización central: hacia la estructuración de un concepto multidisciplinar. Med Clin 152(9):373–374. https://doi.org/10.1016/j.medcli.2018.07.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.medcli.2018.07.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-López O, Jiménez-Hernández B, Alfonso-Almirall R, Sabina-Molina D, Cruz-Navarro JR (2012) Manual para diagnóstico y tratamiento de trastornos ansiosos. Revista Electrónica de las Ciencias Médicas en Cienfuegos 10(5):466–479</Citation>
        </Reference>
        <Reference>
          <Citation>Fitzcharles M, Shir Y, Ablin J, Buskila D, Amital H, Henningsen P, Häuser W (2013) Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines. Evid Based Complement Altern Med 2013:1–9. https://doi.org/10.1155/2013/528952</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/528952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galvez-Sánchez CM, Reyes del Paso GA (2020) Diagnostic criteria for fibromyalgia: critical review and future perspectives. J Clin Med 9(4):1219. https://doi.org/10.3390/jcm9041219</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9041219</ArticleId>
            <ArticleId IdType="pmc">7230253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García Silgo M (2019) Detección de simulación de trastorno mental mediante el MMPI-2-RF, el PAI y el SIMS. Sanidad Militar 75(4):203–213</Citation>
        </Reference>
        <Reference>
          <Citation>González-Ordi H, Santamaría P (2009) Adaptación española del Inventario Estructurado de Simulación de Síntomas—SIMS. TEA Ediciones, Madrid</Citation>
        </Reference>
        <Reference>
          <Citation>González-Ordi H, Santamaría P, Capilla-Ramírez P (2012) Estrategias de detección de la simulación. Un manual clínico multidisciplinar. TEA Ediciones, Madrid</Citation>
        </Reference>
        <Reference>
          <Citation>Greve KW, Ord JS, Bianchini KJ, Curtis KL (2009) Prevalence of malingering in patients with chronic pain referred for psychological evaluation in a medicolegal context. Arch Phys Med Rehabil 90(7):1117–1126. https://doi.org/10.1016/j.apmr.2009.01.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.apmr.2009.01.018</ArticleId>
            <ArticleId IdType="pubmed">19577024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guillén-Riquelme A, Buela-Casal G (2011) Actualización psicométrica y funcionamiento diferencial de los ítems en el State Trait Anxiety Inventory (STAI). Psicothema 23(3):510–515</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21774907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris IA, Murgatroyd D, Cameron I, Young JM, Solomon MJ (2009) The effect of compensation on health care utilisation in a trauma cohort. Med J Aust 190:619–622. https://doi.org/10.5694/j.1326-5377.2009.tb02589.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5694/j.1326-5377.2009.tb02589.x</ArticleId>
            <ArticleId IdType="pubmed">19485839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Häuser W, Brähler E, Ablin J, Wolfe F (2020) 2016 modified American College of Rheumatology fibromyalgia criteria, ACTTION-APS Pain Taxonomy criteria and the prevalence of fibromyalgia. Arthritis Care Res 73(5):617–625</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.24202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YK (ed) (2020) Anxiety disorders. Advances in experimental medicine and biology. Springer. https://doi.org/10.1007/978-981-32-9705-0</Citation>
        </Reference>
        <Reference>
          <Citation>Kirmayer LJ, Robbins JM, Kapusta MA (1988) Somatization and depression in fibromyalgia síndrome. Am J Psychiatry 145(8):950–954</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/ajp.145.8.950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>López-Miquel L, Pujol-Robinatac A (2020) Análisis descriptivo de la simulación de síntomas psicológicos en una muestra forense. Revista Española de Medicina Legal 46(4):175–182</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.reml.2020.01.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Low LA, Schweinhardt P (2012) Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 17(6):140832. https://doi.org/10.1155/2012/140832</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/140832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maffei ME (2020) Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies. Int J Mol Sci 21(21):7877. https://doi.org/10.3390/ijms21217877</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21217877</ArticleId>
            <ArticleId IdType="pmc">7660651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez M, Sánchez A, Miró E, Lami M (2015) Relationships between physical symptoms, emotional distress and pain appraisal 74 in fibromyalgia: the moderator effect of alexithymia. J Psychol 149(2):115–140. https://doi.org/10.1080/00223980.2013.844673</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00223980.2013.844673</ArticleId>
            <ArticleId IdType="pubmed">25511201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez-Lavín M (2021) Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain? Clin Exp Rehumatol 39(2):422–425</Citation>
        </Reference>
        <Reference>
          <Citation>Mascarenhas RO, Souza MB, Oliveira MX, Lacerda AC, Mendonça VA, Henschke N et al (2020) Association of therapies with reduced pain and improved quality of life in patients with fibromyalgia. JAMA Intern Med 181(1):104–112. https://doi.org/10.1001/jamainternmed.2020.5651</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2020.5651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mittenberg W, Patton C, Canyock E, Condit D (2002) Base rates of malingering and symptom exaggeration. J Clin Exp Neuropsychol 24(8):1094–1102. https://doi.org/10.1076/jcen.24.8.1094.8379</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1076/jcen.24.8.1094.8379</ArticleId>
            <ArticleId IdType="pubmed">12650234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monaro M, Toncini A, Ferracuti S, Tessari G, Vaccaro MG, De Fazio P et al (2018) The detection of malingering: a new tool to identify made-up depression. Front Psychiatry 9:1–12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyt.2018.00249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>On AK, Hwang KS, Jang SH, Lee HJ, Soh MJ, Yang CM et al (2019) Detection of malingering using Wechsler Adult Intelligence Scale-IV for psychiatric patients. Psychiatry Investig 17(6):526–532. https://doi.org/10.30773/pi.2019.0330</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.30773/pi.2019.0330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez-Pareja J, Borrás C, Palmer A, Sesé A, Molina F, Gonzalvo J (2004) Fibromialgia y emociones negativas. Psicothema 16(3):415–420</Citation>
        </Reference>
        <Reference>
          <Citation>Rogers R (2018) Clinical assessment of malingering and deception, 4th edn. The Guilford Press, New York</Citation>
        </Reference>
        <Reference>
          <Citation>Rumschik SM, Appel JM (2018) Malingering in the psychiatric emergency department: prevalence, predictors, and outcomes. Psychiatr Serv. https://doi.org/10.1176/appi.ps.201800140</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.ps.201800140</ArticleId>
            <ArticleId IdType="pubmed">30526343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahoo S, Kumar R, Oomer F (2020) Concepts and controversies of malingering: a re-look. Asian J Psychiatry 50:101952. https://doi.org/10.1016/j.ajp.2020.101952</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajp.2020.101952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santamaría P, Capilla-Ramírez P, González-Ordi H (2013) Prevalencia de simulación en incapacidad temporal: percepción de los profesionales de la salud. Clínica y Salud 24(3):139–151. https://doi.org/10.5093/cl2013a15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5093/cl2013a15</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 16:645–660. https://doi.org/10.1038/s41584-020-00506-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41584-020-00506-w</ArticleId>
            <ArticleId IdType="pubmed">33024295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D (2021) Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 22(8):3891. https://doi.org/10.3390/ijms22083891</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22083891</ArticleId>
            <ArticleId IdType="pubmed">33918736</ArticleId>
            <ArticleId IdType="pmc">8068842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallejo MA, Rivera J, Esteve-Vives J, Rodríguez-Muñoz MF (2014) El cuestionario general de salud (GHQ-28) en pacientes con fibromialgia: propiedades psicométricas y adecuación. Clínica y Salud 25(2):105–110. https://doi.org/10.1016/j.clysa.2014.06.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clysa.2014.06.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO (2019) International statistical classification of diseases and related health problems. 11th Revision. World Health Organization, Geneva</Citation>
        </Reference>
        <Reference>
          <Citation>Wolfe F, Brahler E, Hinz A, Hauser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65(5):777–785. https://doi.org/10.1002/acr.21931</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.21931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610. https://doi.org/10.1002/acr.20140</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.20140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yunus M (2008) Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37(6):339–352. https://doi.org/10.1016/j.semarthrit.2007.09.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2007.09.003</ArticleId>
            <ArticleId IdType="pubmed">18191990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yunus M (2012) The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012:1–8. https://doi.org/10.1155/2012/584573</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/584573</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
